基本信息
浏览量:6
职业迁徙
个人简介
Dr Stanley is one of Australia’s highest contributors to the field of poultry intestinal microbiota. Using sequencing technology and 16S rRNA gene to study microbial diversity is a relatively new approach that requires substantial knowledge of microbiology, molecular biology and bioinformatics.
Dr Stanley’s research on intestinal microbiota in health and disease focuses on the role of microbiota in poultry and other agricultural animals, as well as rodent models of human disease. She reported a relationship between intestinal bacteria and the ability of agricultural animals to retain energy from feed as well as the identification of phylotypes responsible for improved weight gain per unit of feed. She is currently developing probiotics with enhanced epigenetic effects to be used in agricultural breeding stock. Complementary to the role of microbiota in health, she is investigating the role of microbiota in disease prevention. Necrotic enteritis (NE) cost the international agricultural industry over $2 billion annually. Although it is widely accepted that Clostridium perfringens is the cause of NE, she proposed in her recent work that NE is considerably more complex than previously realised. She published on NE in 3 manuscripts, noting that 1) Induction of clinical symptoms requires the abundant intestinal bacteria, Weisella confusa, to be removed. She hypothesised that W. confusa, producer of gut epithelium protective mucous, prevents C. perfringens attaching to mucosa. 2) Although C. perfringens numbers increased in sick birds, the other unknown and unclassified order of Mollicutes, also involved in the onset of irritable bowel syndrome, increased much more than C. perfringens. 3) Virulent strain of C. perfringens administered in high doses during an experimental challenge is not capable of establishing itself in healthy birds but only in immuno-compromised hosts. 4) Well-known immunomodulating segmented filamentous bacteria (SFB) play a key role in preventing expansion of C. perfringens.
Additionally, Dr Stanley is a dedicated researcher is the area of poultry gut health and is one of the most published researchers at an international level, in the area of poultry gut heath and the role of optimal intestinal bacterial community in bird performance. Dr Stanley is currently investigating the nanoparticle based delivery of essential minerals and their ability to be used to deliver other treatments, such as antimicrobials and next generation probiotic development as a part of DECRA fellowship project. Dr Stanley is proactive and strongly associated with poultry industry collaborating with major poultry industry producers as evident from the current proposal.
Dana Stanley’s intestinal microbiota agricultural and veterinary research is complemented with human health studies. She established a reputation as a researcher in intestinal microbiota through long-term investigations in human health that resulted in high impact publications. She investigated how metabolic products from microbial fermentation of dietary fibre through metabolite-sensing receptors GPR43 and GPR109A prevent colitis (Nature Communications, 2015, 91 GS citations). Similarly, in another project she co-investigated the mechanisms behind microbiota-induced epigenetic effects in regulating the development of allergic airways disease (Nature Communications, 2015, 59 GS citations). Lastly her most recent manuscript (as a first author) was published in Nature Medicine (impact factor 33) reporting a microbiota role in post stroke mortality. This manuscript is considered game changing in our understanding of stroke mortality. It reveals that stroke event causes massive shock to immune and epithelial signalling system which results in compromised intestinal epithelial integrity and subsequent translocation of intestinal bacteria from the gut into the blood and organs. Gut permeability was highest at 3 hours post stroke, after which time epithelial integrity gets restored, however, a number of species comprising major lung pathogens already reached the lung at this stage and the unusual pneumonia, caused by dozens of different pathogens mounts antibiotic resistant lung infection that cannot be treated with antibiotics. Commonly administered antibiotics cannot cover the whole range of pathogens translocated to the lung. This manuscript received high media attention and was featured in Herald Sun, Morning Bulletin, Daily Telegraph Australia, Brisbane Courier-Mail and a number of radio interviews and it is of high clinical relevance.
Dana’s most recent publication, in Nature Immunology (impact 22), identifies the role of short chain fatty acids in the onset of type 1 diabetes (T1D). The modification of food to allow high concentrations of butyrate and/or acetate in the colon resulted in high level of protection from T1D, while combination of both high acetate and high butyrate provided total protection from T1D in NOD mouse T1D model. The fecal transplant from high acetate protected mice was able to confer protection in germ free recipients fed normal standard chow. Acetate was conferring protection via B-cell and butyrate via T-cell modifications.
Dr Stanley’s research on intestinal microbiota in health and disease focuses on the role of microbiota in poultry and other agricultural animals, as well as rodent models of human disease. She reported a relationship between intestinal bacteria and the ability of agricultural animals to retain energy from feed as well as the identification of phylotypes responsible for improved weight gain per unit of feed. She is currently developing probiotics with enhanced epigenetic effects to be used in agricultural breeding stock. Complementary to the role of microbiota in health, she is investigating the role of microbiota in disease prevention. Necrotic enteritis (NE) cost the international agricultural industry over $2 billion annually. Although it is widely accepted that Clostridium perfringens is the cause of NE, she proposed in her recent work that NE is considerably more complex than previously realised. She published on NE in 3 manuscripts, noting that 1) Induction of clinical symptoms requires the abundant intestinal bacteria, Weisella confusa, to be removed. She hypothesised that W. confusa, producer of gut epithelium protective mucous, prevents C. perfringens attaching to mucosa. 2) Although C. perfringens numbers increased in sick birds, the other unknown and unclassified order of Mollicutes, also involved in the onset of irritable bowel syndrome, increased much more than C. perfringens. 3) Virulent strain of C. perfringens administered in high doses during an experimental challenge is not capable of establishing itself in healthy birds but only in immuno-compromised hosts. 4) Well-known immunomodulating segmented filamentous bacteria (SFB) play a key role in preventing expansion of C. perfringens.
Additionally, Dr Stanley is a dedicated researcher is the area of poultry gut health and is one of the most published researchers at an international level, in the area of poultry gut heath and the role of optimal intestinal bacterial community in bird performance. Dr Stanley is currently investigating the nanoparticle based delivery of essential minerals and their ability to be used to deliver other treatments, such as antimicrobials and next generation probiotic development as a part of DECRA fellowship project. Dr Stanley is proactive and strongly associated with poultry industry collaborating with major poultry industry producers as evident from the current proposal.
Dana Stanley’s intestinal microbiota agricultural and veterinary research is complemented with human health studies. She established a reputation as a researcher in intestinal microbiota through long-term investigations in human health that resulted in high impact publications. She investigated how metabolic products from microbial fermentation of dietary fibre through metabolite-sensing receptors GPR43 and GPR109A prevent colitis (Nature Communications, 2015, 91 GS citations). Similarly, in another project she co-investigated the mechanisms behind microbiota-induced epigenetic effects in regulating the development of allergic airways disease (Nature Communications, 2015, 59 GS citations). Lastly her most recent manuscript (as a first author) was published in Nature Medicine (impact factor 33) reporting a microbiota role in post stroke mortality. This manuscript is considered game changing in our understanding of stroke mortality. It reveals that stroke event causes massive shock to immune and epithelial signalling system which results in compromised intestinal epithelial integrity and subsequent translocation of intestinal bacteria from the gut into the blood and organs. Gut permeability was highest at 3 hours post stroke, after which time epithelial integrity gets restored, however, a number of species comprising major lung pathogens already reached the lung at this stage and the unusual pneumonia, caused by dozens of different pathogens mounts antibiotic resistant lung infection that cannot be treated with antibiotics. Commonly administered antibiotics cannot cover the whole range of pathogens translocated to the lung. This manuscript received high media attention and was featured in Herald Sun, Morning Bulletin, Daily Telegraph Australia, Brisbane Courier-Mail and a number of radio interviews and it is of high clinical relevance.
Dana’s most recent publication, in Nature Immunology (impact 22), identifies the role of short chain fatty acids in the onset of type 1 diabetes (T1D). The modification of food to allow high concentrations of butyrate and/or acetate in the colon resulted in high level of protection from T1D, while combination of both high acetate and high butyrate provided total protection from T1D in NOD mouse T1D model. The fecal transplant from high acetate protected mice was able to confer protection in germ free recipients fed normal standard chow. Acetate was conferring protection via B-cell and butyrate via T-cell modifications.
研究兴趣
论文共 100 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Applied Microbiology and Biotechnologyno. 1 (2024): 142-142
Edina Lobo,Yadav S. Bajagai,Advait Kayal, Santiago Ramirez, Anja Nikolic, Rolando Valientes,Dragana Stanley
ANIMALSno. 1 (2024): 32
ANIMAL NUTRITIONno. 4 (2023): 197-209
Microorganismsno. 3 (2023): 561-561
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn